# Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray and ANTI-ANGIN® FORMULA, Topical Metered Spray in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied by a Sore Throat

> **NCT03095508** · PHASE3 · COMPLETED · sponsor: **Sandoz** · enrollment: 229 (actual)

## Conditions studied

- Sore Throat

## Interventions

- **DRUG:** Angal S, topical spray [Menthol]
- **DRUG:** ANTI-ANGIN® FORMULA, topical metered spray

## Key facts

- **NCT ID:** NCT03095508
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-22
- **Primary completion:** 2017-05-08
- **Final completion:** 2017-05-08
- **Target enrollment:** 229 (ACTUAL)
- **Last updated:** 2019-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03095508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03095508, "Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray and ANTI-ANGIN® FORMULA, Topical Metered Spray in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied by a Sore Throat". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03095508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*